Anne Wojcicki on 23andMe’s Second Life After a data breach and collapse, Anne Wojcicki is rebuilding 23andMe as a nonprofit aimed at democratizing large-scale genetic research. By Sissi Cao
Legendary Educator Esther Wojcicki and Former Student Launch $10M A.I. Health Fund Esther Wojcicki and Mary Minno unveil a new fund and residency program to help academic founders build A.I. health care startups. By Alexandra Tremayne-Pengelly
This Startup Backed By OpenAI and the Jobs Family Is the Latest A.I. Drug Discovery Unicorn Chai Discovery more than doubled its valuation to $1.3 billion after raising $130 million to advance A.I.-powered drug development. By Alexandra Tremayne-Pengelly
Colossal Biosciences Acquires Pet Cloning Company to Advance De-Extinction Efforts By Alexandra Tremayne-Pengelly
The $10B Startup Behind the Revived Dire Wolf Reports Another Breakthrough By Alexandra Tremayne-Pengelly
Sam Altman-Backed Startup Aims to Add 10 Years to Human Life Through Stem Cell Tech By Alexandra Tremayne-Pengelly
23andMe Has Found a Buyer—Here’s What Might Happen to Your Genetic Data By Alexandra Tremayne-Pengelly
Amgen and CEO Robert Bradway Sued for Hiding $10.7 Billion Tax Bill from Investors By Alexandra Tremayne-Pengelly